Contineum Therapeutics, Inc. Class A Stock Performance
as on October 17, 2026 at 2:15 pm IST
Day's Low
Day's High
$6.95$7.84
1.84%
Downside
10.73%
Upside
52 Week's Low
52 Week's High
$6.95$17.791.84%
Downside
151.20%
Upside
Contineum Therapeutics, Inc. Class A share price movements today
- Previous Close
- $7.90
- Open
- $7.84
- Volume
- 1.1M
- Market Cap
- $297.2M
- Day's Low - High
- $6.95 - $7.84
- 52 Week Low - High
- $6.95 - $17.79
Contineum Therapeutics, Inc. Class A Historical Returns
- 1 Month Return
- -46.4 %
- 3 Month Return
- -50.25 %
- 1 Year Return
- -39.49 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Contineum Therapeutics, Inc. Class A Stock Fundamentals & Key Indicators
Check Contineum Therapeutics, Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$297.2M
EPS (TTM)
-1.73
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.57
Industry PE ratio
-6.86
PEG Ratio
-0.19
EBITDA
-66.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-24.73%
Contineum Therapeutics, Inc. Class A vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Contineum Therapeutics, Inc. Class A with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $297.2M | NA | -4.57 | 0.00% | 0.00% | |
| Neutral | $94.4B | -32.76% | -29.64 | -12.57% | 0.00% | |
| StrongBuy | $128.9B | 174.93% | 29.37 | 86.04% | 0.00% | |
| Buy | $80.1B | 42.93% | 19.01 | 84.86% | 0.46% |
Stock Returns calculator for Contineum Therapeutics, Inc. Class A Stock including INR - Dollar returns
The Contineum Therapeutics, Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Contineum Therapeutics, Inc. Class A investment value today
Current value as on today
₹65,392
Returns
Returns from Contineum Therapeutics, Inc. Class A Stock
Dollar Impact
₹4,879 (+4.88%)
Analyst Recommendation on Contineum Therapeutics, Inc. Class A Stock
Based on 5 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Contineum Therapeutics, Inc. Class A. Average target price of $24
Contineum Therapeutics, Inc. Class A Share Price Target
Get share price movements and forecasts by analysts on Contineum Therapeutics, Inc. Class A.
Current Price
$7.08
Analyzed by
5 Analysts
High
$30
Low
$17
Contineum Therapeutics, Inc. Class A target price $0, a slight upside of 0% compared to current price of $7.08. According to 5 analysts rating.
Indian Investors' Interest in Contineum Therapeutics, Inc. Class A Stock
Search interest for Contineum Therapeutics, Inc. Class A Stock has increased by 680% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:680% versus previous 30 day period
Contineum Therapeutics, Inc. Class A Quarterly Profit & Loss
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Annual Profit & Loss
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Quarterly Cash Flow
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Annual Cash Flow
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A News & Key Events
Today's Timeline - 12 October
Mon, 05:26 PM
-Contineum shares fell 25% after initial 27% pre-market surge, despite positive Bristol Myers trial results for pulmonary fibrosis treatment.
Insights on Contineum Therapeutics, Inc. Class A
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 777.7%
NEGATIVE IMPACTPrice Dip
In the last 7 days, CTNM stock has moved down by -47.1%
About Contineum Therapeutics, Inc. Class A
| Organisation | Contineum Therapeutics, Inc. Class A |
| Headquarters | 3565 General Atomics Court Suite 200, San Diego, CA, 92121, US |
| Industry | Biotechnology |
| CEO | Carmine N. Stengone |
Key Management of Contineum Therapeutics, Inc. Class A
Name | Title |
|---|---|
Mr. Carmine N. Stengone MBA, MS | President, CEO & Director |
Mr. Peter T. Slover CPA | Chief Financial Officer |
Mr. Steve E. Kunszabo | Senior Director of Investor Relations & Corporate Communications |
Mr. John S. Healy | General Counsel & Corporate Secretary |
Ms. Kristina Haeckl Rac | Senior Vice President of Regulatory Affairs |
Dr. Timothy R. Watkins M.D., M.Sc. | Chief Medical Officer & Head of Development |
Ms. Morgan Paulsen | Senior Manager of Accounting |
Dr. Daniel S. Lorrain Ph.D. | Chief Science Officer |
Mr. Austin Chen Ph.D. | Senior VP & Head of Research |
Ms. Julie S. Iwashita | Senior Vice President of Clinical Operations |
FAQs
What is Contineum Therapeutics, Inc. Class A share price today?
Contineum Therapeutics, Inc. Class A share price today is $7.08 as on at the close of the market. Contineum Therapeutics, Inc. Class A share today touched a day high of $7.84 and a low of $6.95.
What is the 52 week high and 52 week low for Contineum Therapeutics, Inc. Class A share?
Contineum Therapeutics, Inc. Class A share touched a 52 week high of $17.79 on and a 52 week low of $6.95 on . Contineum Therapeutics, Inc. Class A stock price today i.e. is closed at $7.08,which is 60.19% down from its 52 week high and 1.87% up from its 52 week low.
What is Contineum Therapeutics, Inc. Class A's market capitalisation today?
Contineum Therapeutics, Inc. Class A market capitalisation is $0.00T as on .
How to invest in Contineum Therapeutics, Inc. Class A Stock (CTNM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Contineum Therapeutics, Inc. Class A on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Contineum Therapeutics, Inc. Class A Stock (CTNM) from India?
Indian investors can start investing in Contineum Therapeutics, Inc. Class A (CTNM) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Contineum Therapeutics, Inc. Class A stock (as per the Rupee-Dollar exchange rate as on ).
Based on Contineum Therapeutics, Inc. Class A share’s latest price of $7.08 as on October 17, 2026 at 8:45 am IST, you will get 1.4124 shares of Contineum Therapeutics, Inc. Class A. Learn more about
fractional shares .